Public comments invited by the Health Ministry on the draft New Drugs and Clinical Trials (Amendment) Rules, 2022 till 7th December, 2022 by Lexplosion Solution | Nov 29, 2022 | Central, Drug, OPSYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Amendments underway to the Drugs Rules, 1945; proposes to cast compliance obligations upon drug manufacturers to affix Bar Codes and Quick Response Codes on labels of specific drugs from 1st May, 2023;public comments invited till 14th July, 2022 by Lexplosion Solution | Jun 24, 2022 | Central, Drug, OPSYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Amendments underway to the Drugs Rules; proposes parallel submission of applications for grant of renewal of manufacturing and sales license for large volume parenterals, vaccines and (r-DNA) derived drugs etc. comments invited till 22.06.202 by Lexplosion Solution | Jun 2, 2022 | Central, Drug, OPSYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Health Ministry notifies the Drugs (3rd Amendment) Rules, 2022; introduces new colour ‘Allura Red’ to list of colours permitted to be used in drugs by Lexplosion Solution | Mar 22, 2022 | Central, Drug, OPSYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
MOHFW issues the draft New Drugs and Clinical Trials (……Amendment) Rules, 2021; objections and suggestions invited by 11th December, 2021 by Lexplosion Solution | Nov 1, 2021 | Central, Drug, OPSYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More